p53 is one of the most important tumor suppressor genes. Mutation of the p5
3 gene can be detected immunohistochemically as over-expression of its prot
ein in the nucleus. The p53 gene product is known to regulate cell growth a
nd proliferation. Genetic alterations related to the carcinogenesis or prog
ression of esophageal cancer are poorly understood. We examined accumulatio
n of p53 protein in esophageal squamous cell carcinomas including early-sta
ge cancers, and its clinicopathological significance. p53 immunoreactivity
in the cancer tissues was found in 61 (79.2%) of 77 esophageal squamous cel
l carcinomas. Over-expression of p53 protein (diffusely and focally positiv
e staining) was seen in 70.1% (54/77). p53 over-expression was detected not
only in the cases of in situ or intramucosal carcinomas, but also in invas
ive carcinomas. No significant correlations were found between p53 over-exp
ression and clinicopathological features such as depth of tumor invasion, l
ymph node metastasis or venous/lymphatic invasion. These results suggested
that p53 mutations may be closely associated with the early-stage of pre-in
vasive esophageal carcinoma, and p53 gene mutations may play an important r
ole in the carcinogenesis of human esophageal cancer.